• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET meets universal cancer screening

Article

Ever wonder what could be learned about the incidence of cancer if everyone was scanned?

Ever wonder what could be learned about the incidence of cancer if everyone was scanned?

This may be an outrageous question to pose in the U.S., but not so in Japan, where healthcare consumers have always been fascinated by the diagnostic possibilities of ad¬vanced imaging technology. The Japanese Ministry of Health, Labor, and Welfare is considering the possibility of universal cancer screening. Survey results from 92 PET and PET/CT imaging services identified verifiable results from 88,224 FDG-PET cancer screenings performed in 2005 and 2006.

By analyzing those cases, Dr. Ryogo Minaminoto and colleagues at four Japanese hospitals and clinics identified 922 cases of previously undetected cancer. The incidence rate was 1.04%. Colon/rectum, thyroid, lung, and breast cancers were the most common metastatic conditions uncovered by the screenings. The sensitivities of the imaging exams were 87%, 89%, 81%, and 88%, respectively.

Minaminoto concluded that the number of PET centers in Japan is growing steadily, highlighting the need to evaluate the usefulness of PET cancer screening.

Results were described in June in a scientific poster displayed at the 2008 SNM conference.

-By James Brice

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.